Cambridge Investment Research Advisors, Inc. Ark Genomic Revolution ETF (De Transaction History
Cambridge Investment Research Advisors, Inc.
- $26 Billion
- Q1 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 115,384 shares of ARKG stock, worth $2.71 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
115,384
Previous 123,885
6.86%
Holding current value
$2.71 Million
Previous $4.07 Million
18.38%
% of portfolio
0.01%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding ARKG
# of Institutions
316Shares Held
19.1MCall Options Held
1.49MPut Options Held
2.83M-
Main Management ETF Advisors, LLC San Francisco, CA2.69MShares$63.2 Million4.12% of portfolio
-
Morgan Stanley New York, NY1.96MShares$45.9 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA1.3MShares$30.6 Million0.01% of portfolio
-
Ubs Group Ag1.27MShares$29.8 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY1.13MShares$26.5 Million0.0% of portfolio